← Open Payments lookup

OLIVIA MOTSIS: Open Payments

NPI 1306419460 · NEWBURYPORT, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$971 in 41 payments from 11 companies in 2025. Trend: 2023 $840 · 2024 $582 · 2025 $971

Food & beverage: $971
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP10$255
E.R. Squibb & Sons, L.L.C.15$245
Edwards Lifesciences Corporation1$124
PFIZER INC.4$107
Novartis Pharmaceuticals Corporation3$49
Esperion Therapeutics, Inc.2$42
Philips North America LLC1$41
Amgen Inc.2$38
Boehringer Ingelheim Pharmaceuticals, Inc.1$25
Actelion Pharmaceuticals US, Inc.1$22

Products named: CAMZYOS, FARXIGA, SAPIEN 3 Ultra RESILIA, ELIQUIS, WAINUA, LEQVIO, NEXLETOL, Extended Holter.

Industry payments across MA — which companies pay providers there.